🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

27,79 USD

Máx. histórico

61,71

1723 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-54,97%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-2,32%

Cierre anterior

28,45

Rango de hoy

27,72 – 28,15

Volumen hoy

31.727.745

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
36,57 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,19%
Fecha de pago Importe por participación
31/07/1996 0,0474 USD
08/05/1996 0,0474 USD
07/02/1996 0,0474 USD
08/11/1995 0,0411 USD
02/08/1995 0,0411 USD
08/05/1995 0,0411 USD
06/02/1995 0,0411 USD
04/11/1994 0,0372 USD
01/08/1994 0,0372 USD
09/05/1994 0,0372 USD
07/02/1994 0,0372 USD
05/11/1993 0,0332 USD
02/08/1993 0,0332 USD
10/05/1993 0,0332 USD
08/02/1993 0,0332 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/01/1996 9,82 10,00 9,76 9,98 +2,23% 2,41% 7.636.862
15/01/1996 9,74 9,84 9,63 9,76 +0,41% 2,23% 5.527.176
12/01/1996 9,76 9,86 9,72 9,72 -0,40% 1,42% 8.982.610
11/01/1996 10,00 10,04 9,69 9,76 -1,98% 3,56% 10.587.641
10/01/1996 10,06 10,20 9,90 9,96 -3,82% 2,95% 7.567.931
09/01/1996 10,26 10,50 10,20 10,36 +1,95% 2,89% 10.186.067
08/01/1996 10,04 10,18 10,04 10,16 +1,18% 1,38% 2.159.014
05/01/1996 10,08 10,10 9,90 10,04 -1,36% 1,96% 6.321.470
04/01/1996 9,90 10,18 9,90 10,18 +3,83% 2,79% 10.710.326
03/01/1996 9,84 9,92 9,72 9,80 -0,40% 2,01% 10.838.071
02/01/1996 9,88 9,92 9,63 9,84 -1,19% 3,00% 8.112.427
29/12/1995 9,88 9,96 9,74 9,96 +0,60% 2,20% 5.197.696
28/12/1995 9,96 10,02 9,88 9,90 -0,59% 1,39% 4.630.433
27/12/1995 9,98 10,06 9,92 9,96 -0,40% 1,39% 4.930.190
26/12/1995 9,88 10,02 9,88 10,00 +1,20% 1,40% 4.366.090
22/12/1995 9,84 10,00 9,78 9,88 +0,60% 2,21% 4.802.446
21/12/1995 9,72 9,84 9,72 9,82 +1,02% 1,22% 9.372.168
20/12/1995 10,00 10,02 9,72 9,72 -2,77% 2,96% 8.047.290
19/12/1995 10,08 10,14 9,94 10,00 -1,94% 1,96% 8.383.094
18/12/1995 10,22 10,38 10,10 10,20 -1,71% 2,71% 8.595.581
15/12/1995 10,50 10,56 10,34 10,38 -0,94% 2,07% 18.358.572
14/12/1995 10,36 10,57 10,32 10,48 +1,73% 2,48% 12.456.383
13/12/1995 10,38 10,38 10,22 10,30 -0,57% 1,52% 6.538.384
12/12/1995 10,14 10,36 10,12 10,36 +2,14% 2,34% 7.653.305
11/12/1995 10,06 10,20 10,06 10,14 +0,79% 1,37% 6.360.679
08/12/1995 10,24 10,24 10,00 10,06 -1,36% 2,32% 7.452.202
07/12/1995 10,24 10,24 10,04 10,20 -0,39% 1,93% 7.016.478
06/12/1995 10,14 10,24 9,98 10,24 +1,17% 2,53% 9.150.196
05/12/1995 9,78 10,14 9,76 10,12 +4,70% 3,84% 12.682.150
04/12/1995 9,37 9,72 9,31 9,67 +4,49% 4,43% 12.913.608